UP: Umbilical or Peripheral Catheter Insertion for Preterm Infants on Admission to the NICU

Sponsor
University College Dublin (Other)
Overall Status
Recruiting
CT.gov ID
NCT04761484
Collaborator
Irish Research Council (Other)
116
1
2
19
6.1

Study Details

Study Description

Brief Summary

Preterm infants are at risk of hypothermia following delivery and in the first few hours of life. Hypothermia in extremely low birth weight infants' is an independent risk factor for death. These infants' are at additional risk of hypothermia when they undergo procedures such as central catheter insertion following admission.

The investigators think that in extremely preterm infants, placing a peripheral intravenous cannula on admission to the NICU, instead of umbilical catheters (UVC and/or UAC), will increase the proportion of infants with a rectal temperature in the normal range at 2 hours of life.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Vascular access on admission
N/A

Detailed Description

Hypothermia is an independent risk factor for death in preterm newborns.(1) Despite measures to improve temperature in preterm newborns in the delivery room (DR), hypothermia on admission to the neonatal intensive care unit (NICU) at NMH is common. In a cohort of infants < 32 weeks' gestation born at NMH in 2019, 54% of infants had a rectal temperature < 36.5 oC on admission to the NICU.(2)

Many preterm infants have procedures performed soon after admission to the NICU; in 2019, 98% of infants born before 29 weeks' gestation at NMH had an umbilical venous catheter inserted. This may/often involve(s) prolonged periods of handling and potential exposure to cold.

The investigators prospectively studied a cohort of 26 infants < 32 weeks who had invasive procedures within 3 hours of birth performed in the NICU at NMH between November 2018 and June 2019. Almost three-quarters [19/26 (73%)] had an abnormal temperature at the beginning of the procedure; and 17/26 (65%) had an abnormal temperature at the end of the procedure. Only 3 (11%) infants maintained a normal temperature throughout the procedure. Perhaps more concerning is the severity of the hypothermia observed; 13 (50%) infants had a temperature < 36.0oC before and 11 (42%) after the procedure. The median duration of procedure was 53 (37, 73) minutes.(3)

The investigators think that in extremely preterm infants, placing a peripheral intravenous cannula on admission to the NICU, instead of umbilical catheters (UVC and/or UAC), will increase the proportion of infants with a rectal temperature in the normal range at 2 hours of life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
116 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomly assigned in blocks of 4 in a 1:1 ratio, stratified by GA (23 - 25+6, 26 - 28+6) and by admission temperature (normal temperature [36.5oC- 37.5oC] , abnormal temperature [<36.5oC or >37.5oC]).Randomly assigned in blocks of 4 in a 1:1 ratio, stratified by GA (23 - 25+6, 26 - 28+6) and by admission temperature (normal temperature [36.5oC- 37.5oC] , abnormal temperature [<36.5oC or >37.5oC]).
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Randomised Trial of Umbilical or Peripheral Catheter Insertion for Preterm Infants on NICU Admission
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Insertion of peripheral venous catheter on admission to the NICU

Procedure: Vascular access on admission
PIVC insertion

No Intervention: Control

Insertion of and umbilical venous catheter on admission

Outcome Measures

Primary Outcome Measures

  1. Core (rectal) temperature 2 hours after birth [2 hours]

    Core (rectal) temperature 2 hours after birth

Secondary Outcome Measures

  1. Axillary temperature at the end of the procedure [up to 24 hours]

  2. Mean difference in axillary temperature from admission to end of procedure [up to 24 hours]

  3. Time to completion of procedure (incubator roof down, portholes closed and hands off) [up to 24 hours]

  4. Time to first intravenous infusion starting (PN / dextrose / antibiotics / caffeine) [up to 24 hours]

  5. Number (%) infants that have umbilical catheters inserted during their admission [up to 24 hours]

  6. Number (%) lines used without repositioning [up to 24 hours]

  7. Number (%) lines repositioned [up to 24 hours]

  8. Number (%) of low lying umbilical venous catheters [up to 24 hours]

  9. Number (%) of infants' in whom attempted placement of an umbilical line was not successful [up to 24 hours]

    Definition: an attempt made to insert a central catheter that is not used at any point during the infant's admission (i.e. nothing was infused through the line)

  10. Number of peripheral line attempts [up to 24 hours]

  11. Number (%) of infants in whom PIVC as first point of access was unsuccessful (nothing was infused through the line) [24 hours]

  12. Complications of line insertion/placement [10 days]

  13. Blood stream infections (CRBSI) [up to 16 weeks]

  14. Number of x-rays performed in first 24 hours [24 hours]

  15. Blood sampling in first 24 hours [24 hours]

  16. Number of blood tests in 72 hours [3 days]

  17. Number of blood transfusions during hospital stay [up to 26 weeks]

  18. Peripheral arterial line insertion in the first 7 days of life [7 days]

  19. PICC line insertion in the first 7 days of life [7 days]

  20. Inotropes administered in the first 72 hours of life [3 days]

  21. Intubation + Ventilation [Up to 3 days]

  22. Surfactant administration [up to 3 days]

  23. Necrotizing enterocolitis (Bell's staging) [Up to 3 months]

  24. Intraventricular Haemorrhage (Papile classification) [Up to 6 months]

  25. Periventricular leukomalacia [Up to 6 months]

  26. Chronic lung disease [Up to 3 months]

  27. In hospital mortality [Up to 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Minute to 60 Minutes
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • inborn infants admitted to the NICU with;

  • gestational age < 29 weeks (up to 28+6 weeks) OR

  • birth weight < 1250g.

Exclusion Criteria:
  • end of life (palliative) care

  • large abdominal wall defects

  • imperforate anus.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Maternity Hospital Dublin Dubiln Ireland 2

Sponsors and Collaborators

  • University College Dublin
  • Irish Research Council

Investigators

  • Principal Investigator: Colm PF O'Donnell, MB BCh BAO, The National Maternity Hospital
  • Principal Investigator: Lisa K McCarthy, MB BCh BAO, The National Maternity Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University College Dublin
ClinicalTrials.gov Identifier:
NCT04761484
Other Study ID Numbers:
  • APOLLO_UP
First Posted:
Feb 21, 2021
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2021